Thiazide diuretics have been used in the treatment of arterial hypertension either alone or to potentiate the action of hypotensive drugs (Aleksandrow, Wysznacka, and Gajewski, 1959) .
Thiazides have a hyperuricaemic action due to a specific inhibition of the tubular secretion of uric acid (Demartini, 1965) . A paradoxical uricosuric effect is produced when the drug is administered intravenously (Nash and Kirkendall, 1962) . This hyperuricaemic action appears not only with thiazide derivatives but also with other diuretics not chemically related to them (Melvin, Farrelly, and North, 1963; Humphreys, 1966) . We have recently demonstrated this hyperuricaemic effect in two diuretics, polythiazide and clopamide (Table I ). The data shown in this Table indicate that many thiazide derivatives have a similar hyperuricaemic effect. On the other hand several authors have observed a significantly higher serum uric acid (SUA) level in hypertensive patients with apparently normal glomerular filtration rate (GFR) before treatment in comparison with a normal group. This effect has been attributed to a tubular lesion, probably specific in these patients (Breckenridge, 1966) . It is also known that different hypotensive drugs may produce hyperuricaemia, probably related to a decrease in GFR (Dollery, Duncan, and Schumer, 1962) .
In gout the incidence of arterial hypertension with or without overt renal damage seems to be higher than in the general population (Hall, 1966; Talbott, 1964 To control diuretic-induced hyperuricaemia salicylates (Scott, 1966), probenecid (Brest, Heider, Mehbod, and Onesti, 1966) , sulphinpyrazone (Sperber, Fisch, DeGraaff, and Freudenthal, 1965) , or high doses of potassium and ammonium chloride (Zwaifler and Thompson, 1965) have been used. This paper shows how diuretic-induced hyperuricaemia was prevented by the administration of allopurinol (HPP). (20) Four normal individuals (1-4), six hypertensives with normal renal function (6-10), four hypertensives with chronic renal failure (11-14) (GFR less than 60 ml./min.), and six hypertensive gouty patients (two with normal renal function (15-16) and four with chronic renal failure (17-20)) were admitted to hospital. Urinary uric acid (UUA) and creatinine excretion were determined on a purine-free diet with periodic estimations of SUA, serum creatinine, and serum electrolytes. Blood pressure was measured twice daily.
In all patients SUA was first reduced to normal with allopurinol (300 to 600 mg./day, depending on the response) and after a week of stable results a known hyperuricaemic dose of either Polythiazide (1 mg./day) or Clopamide (40 mg./day) was given orally for one week. Eighteen patients regularly attending the out-patient clinic were instructed in the careful collection of 24-hr urine samples on a low-purine diet. In these patients SUA, serum creatinine and electrolytes, and UUA and creatinine excretion were determined biweekly. Five were hypertensive patients (21-25) (hyperuricaemic during the chronic administration of thiazides) and thirteen were hypertensive gouty patients (26-38) (all with normal GFR). In all of the gouty group except three the uricaemia had previously been reduced to normal with allopurinol; thiazides were later added for better control of blood pressure. In four cases (25, 29, 32, 35 ) guanethidine or reserpine was added at the same time.
The period of study ranged from 4 to 12 months (mean 6 -2). Hepatic function and peripheral blood were studied at monthly intervals. The gouty patients were encouraged to drink a copious fluid intake and also received maintenance doses of colchicine.
Serum and urinary creatinine were determined by the Folin-Wu method and SUA and UUA by the method of Caraway (1955) ; in some the differential spectrophotometric method with uricase was used (Praetorius, 1949) .
Results
In-patient Study (Table II, group.bmj.com on August 28, 2017 -Published by http://ard.bmj.com/ Downloaded from previously treated with allopurinol, thiazide administration neither increased SUA nor lowered Curate significantly (Fig. 1) .
Gouty Hypertensive Patients with Impaired Renal Function (Cases 17-20).-A decrease in GFR was observed without a hyperuricaemic response or variation in urate clearance. This caused a rise in ratio of urate to creatinine clearance (Fig. 1 ). An example of this group (Case 18) is shown in Fig. 3 Out-Patient Study (Table III, opposite) Hypertensives with Thiazide-induced Hyperuricaemia (Cases 21-25).-In all the cases after allopurinol administration SUA returned to normal and the same occurred in UUA (Fig. 4) .
Gouty Hypertensives (Cases 26-38 ).-In the group previously treated with thiazide, allopurinol administration caused a return of SUA to normal values and diminished 24-hour UUA excretion. In the group previously treated with allopurinol, diuretic administration produced no significant differences in either SUA or UUA (Fig. 4) . 
Other Effects
On Blood Pressure.-The hypotensive action observed with diuretic administration was not modified by allopurinol administration.
On Articular Symptoms.-In five of the nineteen gouty patients in whom the SUA had been previously restored to normal by allopurinol, thiazide precipitated an acute attack, mainly at the beginning of treatment (e.g. Fig. 3) . These all showed a SUA level appreciably lower than before treatment. In one case diuretic administration had to be discontinued but in the others the acute attack was easily controlled by increasing the colchicine dosage. No acute articular symptoms were observed in the normal controls or in the hypertensive group.
Other Side-effects.-During this study no significant side-effects were seen; there were no alterations in the blood picture or hepatic function during allopurinol administration.
Discussion
In allopurinol-treated patients there was a decrease in SUA and UUA without significant changes in Curate, GFR, and the ratio of urate to creatinine clearance. These changes were consistent 
